Read an interview with Marianne Takki, Head of Unit for Disease Prevention and Health Promotion at the European Commission

As COVID-19 transitions from a pandemic to an endemic disease, its integration into the broader policy and healthcare framework for respiratory diseases becomes imperative.

Cardiovascular diseases remain the leading cause of death in the EU, claiming 1.7 million lives lost each year.

This first episode positions life course immunisation within the global health landscape, framing it alongside the UN Sustainable Development Goals, the WHO European Immunisation Agenda 2030 and broader health equity aims.

What are the causes for the steady and at times dramatic decline in vaccine confidence seen since the mid-90’s across certain age-groups and communities? Why has the public discourse changed?

Governments can become involved in academic research to assist in public health decision-making. However, when governments become involved, the research process can be influenced away from academic research practices, jeopardizing research integrity.

Life sciences drive innovation in medicine, food and sustainable production, adding nearly €1.5 trillion in value to the EU economy and supporting 29 million jobs across the European Union.

Croatia, Estonia, France, Germany, Lithuania, Slovenia and Spain produced an information note highlighting the loss of confidence in science and health authorities, representing a major challenge for democracies.